14.03.2014 Views

SLEEP 2011 Abstract Supplement

SLEEP 2011 Abstract Supplement

SLEEP 2011 Abstract Supplement

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

B. Clinical Sleep Science V. Sleep Disorders – Movement Disorders<br />

0579<br />

ELEVATED C-REACTIVE PROTEIN (CRP), BUT NOT<br />

INTERLEUKIN-6 (IL-6) OR TUMOR NECROSIS FACTOR<br />

ALPHA (TNF-A), IS ASSOCIATED WITH PERIODIC LIMB<br />

MOVEMENTS (PLMS)<br />

Trotti L 1 , Rye DB 1 , De Staercke C 2 , Hooper C 2 , Quyyumi A 3 ,<br />

Bliwise DL 1<br />

1<br />

Program in Sleep/Department of Neurology, Emory University School<br />

of Medicine, Atlanta, GA, USA, 2 Division of Blood Disorders, Center<br />

for Disease Control and Prevention, Atlanta, GA, USA, 3 Division of<br />

Cardiology, Emory University School of Medicine, Atlanta, GA, USA<br />

Introduction: The inflammatory markers CRP, IL-6, and TNF-a are associated<br />

with cardiovascular disease risk and with some conditions of<br />

disordered sleep, including obstructive sleep apnea. While restless legs<br />

syndrome is known to be associated with cardiovascular disease, the<br />

mechanism for this relationship is unknown. We evaluated the association<br />

between PLMS and inflammation as a possible mechanism for this<br />

relationship.<br />

Methods: A convenience sample was assembled of 167 RLS and/or<br />

PLMS patients evaluated at the Emory Sleep Center for whom leg actigraphy<br />

(PAM-RL, Philips Respironics) results were available while the<br />

patients were not taking dopaminergic, opiate, or gabapentin medications.<br />

Banked plasma was assayed for hsCRP by nephelometry (Dade-<br />

Behring) and for IL-6 and TNF-a by fluorokine multianalyte profiling<br />

(R&D Systems). CRP was categorized as low-normal ( 10 were excluded as likely reflecting acute inflammation.<br />

IL-6 and TNF-a were divided into quartiles and lowest versus<br />

highest quartiles compared. Information about subjects’ demographic<br />

and clinical features was collected from research and clinical databases.<br />

Results: Mean PLMI was significantly higher among those with elevated<br />

CRP levels (40.2/hr vs 26.1/hr, t = -2.10, p = 0.04), but did not<br />

differ between those with high versus low IL-6 or high versus low TNFa.<br />

In an unadjusted logistic regression model, the OR for each PLM/hr<br />

was 1.015 (95% CI 1.003, 1.03). After adjustment for age, race, gender,<br />

diabetes, hypertension, hyperlipidemia, CRP-lowering medications, and<br />

clinically-suspected sleep apnea, the OR for each incremental PLM/hr<br />

was 1.016 (1.001, 1.03).<br />

Conclusion: PLMS are associated with increased CRP, with a single<br />

PLM per hour corresponding to a 1.5% increased risk for elevated CRP.<br />

After controlling for relevant confounders, the relationship between<br />

PLMS and CRP remains apparent. Further investigation into the relationship<br />

between PLMS and inflammation is warranted.<br />

Support (If Any): KL2 RR-025009 (LMT)<br />

0580<br />

THE MU OPIATE RECEPTOR KNOCK-OUT MOUSE SHOWS<br />

INCREASED SENSITIVITY TO PAIN, INCREASED MOTOR<br />

ACTIVITY DURING THE <strong>SLEEP</strong> PERIOD AND DECREASED<br />

SERUM IRON PARALLEL TO HUMAN RESTLESS LEGS<br />

SYNDROME<br />

Walters AS 1 , DeAndrade MP 2,3 , Doroodchi A 3 , Li Y 2,3<br />

1<br />

Neurology, Vanderbilt University School of Medicine, Nashville, TN,<br />

USA, 2 Graduate Biomedical Sciences - Pathobiology and Molecular<br />

Medicine, University of Alabama, Birmingham, AL, USA, 3 Center for<br />

Neurodegeneration and Experimental Therapeutics, Department of<br />

Neurology, University of Alabama, Birmingham, AL, USA<br />

Introduction: Opioids are a well accepted second line therapeutic agent<br />

for Restless Legs Syndrome(RLS). The opioid effect is opiate receptor<br />

specific based upon receptor blocking studies. We have previously<br />

shown in an autopsy study and in an in-vitro animal model that hypofunction<br />

of the endogenous opioid system seems to play a role in RLS.<br />

Our data and the data of others, in combination, suggest that RLS is<br />

characterized by relative deficiencies in the endogenous opioid, dopamine<br />

and iron systems.<br />

Methods: In the current in-vivo study we utilized mu opiate receptor<br />

Oprm1 knock-out mice and control (wild type) mice. We studied serum<br />

iron and the circadian pattern of motor activity as measured by wheel<br />

running.<br />

Results: The Oprm1 knock out mouse is characterized by an increased<br />

sensitivity to pain as has been demonstrated in human RLS in 2 different<br />

studies. In mice the sleeping period is during the day. In the Oprm<br />

1 knock out mouse there is increased motor activity during the normal<br />

sleeping period compared to controls as in human RLS (P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!